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Severe acute respiratory infection with influenza A (H1N1) 
during pregnancy
Eduard Langenegger, André Coetzee, Samier Jacobs, Alrisah le Roux, Gerhard Theron
To the Editor: Pregnant women are at high risk of severe acute 
respiratory infection if infected with the influenza A (H1N1) 
virus. On 14 August 2009 the first complicated H1N1 obstetric 
patient was admitted to the obstetric critical care unit (OCCU) 
at Tygerberg Hospital with respiratory distress. The clinical 
picture was that of bronchopneumonia, and she tested positive 
for H1N1. Subsequent pregnant patients admitted to the OCCU 
with respiratory compromise or flu symptoms were screened 
for the virus.
Eleven days later 13 cases were confirmed. Five patients 
had acute lung injury and required ventilation and inotropic 
support. Three of the patients with acute lung injury 
subsequently died. Three patients required continuous positive 
airway pressure (CPAP) support only, with no inotropics 
needed. The remaining 5 patients presented early, received 
oseltamivir within 48 hours and did not require critical care 
admission. 
All the patients admitted to the OCCU and the medical 
intensive care unit (ICU) initially presented with flu symptoms, 
respiratory distress and changes on the chest radiograph 
indicating an active diffuse pulmonary parenchymal process. 
Six patients underwent uncomplicated caesarean sections for 
fetal distress after they were stabilised. Maternal and neonatal 
outcomes varied. The key factor appears to be early clinical 
diagnosis and oseltamivir within 48 hours of the onset of 
symptoms. The demographic data and maternal and fetal 
outcomes are set out in Table I.
Comments on critical care management
1.   Severe and relatively fast-onset acute lung injury with 
pulmonary shunts in excess of 50% and lung compliance in the 
region of 10 - 15 ml/cm H2O warranted high inspired oxygen 
concentrations and positive end-expiratory pressure (PEEP) 
settings (in the order of 15 - 22 cm H2O).
2.   Acute and severe pulmonary hypertension, as is 
commonly found in acute lung injury (mean pulmonary artery 
pressures in the region of 40 - 45 mmHg),1 appeared not overtly 
due to spasm, as sildenafil (by mouth) did not decrease the 
pressure or improve the right heart output.
3.   Acute (and predictable) right heart failure as measured 
by decreased stroke work despite raised effective pulmonary 
artery elastance often manifested with a raised central venous 
pressure.
4.   Ineffective circulation as gauged by a mixed venous 
desaturation in the order of 50% was often excacerbated by a 
raised temperature, which resulted in a raised VO2 and hence 
lowered the mixed venous saturation.
5.   The partial arterial carbon dioxide level (PaCO2)was 
often raised. This hypercapnia, and the resultant respiratory 
acidosis, was accepted as part of the management strategy. 
The hypercapnia was unlikely only to have been due to lower 
tidal volumes (as part of the lung protective strategy), and may 
also have been caused by an increase in dead space (due to 
an increase in ventilatory frequency mandated by an attempt 
to maintain an acceptable minute ventilation) and possibly 
intrapulmonary arterial clots (which have been shown to occur 
in patients with acute lung injury).1 The difference between the 
PeCO2 and PaCO2 (as a substitute for the proper Bohr equation 
which required average expired CO2) supports the contention 
that the patients suffered from excessive high ventilation 
perfusion (dead space) lung units. In this regard the high 
PEEP may have contributed to intra-alveolar vessel occlusion, 
although the effect of PEEP is to a large extent buffered by poor 
compliance of the lungs.
6.   From a management point of view implementation 
of the protective lung ventilation strategy is suggested, and 
in particular the physician should not attempt to normalise 
the PaCO2 by increasing the ventilation. By  increasing the 
minute ventilation (whether with an increase in frequency or 
respiratory rate) one will only further load the right ventricle 
(and limit the cardiac output with the predicted effect on mixed 
venous saturation). If the raised carbon dioxide is partially 
the result of the dead space lung lesion, increasing the minute 
ventilation will not necessarily result in an improved PaCO2.
7.   If and when the intrapulmonary shunt is severe, as was 
seen in our cases, optimisation of factors that could affect the 
mixed venous saturation becomes of prime importance. These 
can be deduced from the adapted Fick equation: CvO2 = CaO2 
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– VO2/CO, where CvO2 = mixed venous oxygen content, CaO2 
= arterial oxygen content, VO2 = oxygen consumption and CO 
= cardiac output. Attempts to normalise a raised temperature 
will improve mixed venous saturation; maintenance of a 
‘higher’ haemoglobin (perhaps 12 g/dl) and inotrope support 
of the right ventricle are essential adjuncts. We do not suggest 
that this approach will improve survival (there are no data to 
indicate this), but it did assist with the oxygenation problem 
experienced by our patients. 
8.   Because of the poor lung volume, the patients were 
distressed and ventilation was difficult. Allowing for attempts 
at spontaneous respiration is useful, but sufficient support is 
required. Towards this end intermittent mandatory ventilation 
(IMV) with CPAP (the latter assisted by pressure-support 
ventilation (PSV)) worked in some and bilevel positive airway 
pressure (BIPAP) (again with PSV) gave reasonable results in 
others. The PSV on top of the CPAP (either for the IMV/CPAP 
or the P2 during BIPAP) was necessary because the patients 
could not sustain spontaneous breathing. When spontaneous 
breathing was allowed the patients seemed more comfortable, 
but the PSV needed to be carefully adjusted keeping in mind 
their inability to manage a compliance of 10 - 20 ml/cm H2O.
9.  In one of the critically ill patients on adrenaline, the 
paracetamol blood concentration (1 hour after nasogastric 
administration) was not detectable. We measured this in an 
attempt to (crudely) try to gauge the effectiveness of gut 
absorption, which may well be of significant importance 
for the absorption of oseltamivir. If gut absorption is poor 
(which will not be surprising given the severity of illness and 
use of adrenaline), it cannot be certain whether oseltamivir 
is absorbed at all. This question will require a much more 
detailed and expert study. 
10.   Autopsy confirmed what had been suspected clinically 
– solid, heavy lungs, with little (overt) pulmonary oedema. 
Generally speaking the lungs looked very much like lungs 
in the inflammatory (or past the initial oedema) stage of 
acute lung injury. The macroscopic impression was that of 
severe acute lung injury (which during life the Murray score 
had shown that it indeed was).2 The heart was enlarged, 
and although there is reason to suggest right ventricular 
enlargement, the impression of left heart enlargement is 
difficult to explain apart from a viral myocarditis or reversible 
global myopathy associated with severe inflammation (and 
sepsis) as possible cause.3 At the time of writing the histological 
report was not yet available.
Comments on obstetric critical care 
management
1.   Screen all pregnant and newly delivered patients with 
respiratory compromise and SIRS (systemic inflammatory 
response syndrome) for the H1N1 virus.
2.   Commence oseltamivir treatment immediately when an 
obstetric patient presents with flu symptoms, with or without 
respiratory compromise. If gut absorption is poor in the later 
stages of the disease, early administration of the drug is 
particularly important.
3.   Admit stable patients with moderate and severe 
respiratory symptoms (dyspnoea, respiratory rate >24/min) to 
a dedicated observation area, as they may deteriorate rapidly.
4.   Early transfer to high care and ICU is essential when 
respiratory distress develops.
5.   Attempts should be made to stabilise the patient first, 
followed by a systemic evaluation.
6.   Betamethasone must be administered if the fetus is viable 
and the gestational age under 34 weeks.
7.   The patient should be evaluated by an anaesthetist. 
8.   Monitor the fetus only when the patient is stabilised and 
fit for anaesthetic if the fetus is considered to be viable.
9.   Early delivery by caesarean section is advisable if the 
gestational age is ≥34 weeks and the patient is critically ill 
requiring ventilation. Consider postponing delivery by 24 
- 48 hours after the first betamethasone dose if the fetus is 
viable and the gestational age less than 34 weeks, provided 
the mother is stable, the fetal condition is satisfactory, and the 
mixed venous saturation can be maintained around 70%.
Table I. Demographic details of patients and outcomes
             Organ dysfunction  Respiratory  
Age (yrs)       Gestation (wks)        Obstetrics    Oseltamivir <48 h       at admission  support required   Outcome        Pregnancy
25  40        Low risk               Yes        Respiratory  CPAP    Home         Alive, well
34  31        Preterm labour               No        ALI   Invasive ventilation   Death         Neonatal ward, well
20  32        Eclampsia               Yes        Respiratory  CPAP    Home         Home, well
29  27        HIV pos., CD4 497          No        ALI, ARF  Invasive ventilation   Death         IUD
19  30        Low risk               No        ALI, ARF, DIC  Invasive ventilation   Death         ENND
35  28        Pre-eclampsia               Yes        Respiratory  CPAP    Home         Neonatal ward, well
41  40        Low risk               No        ALI   Invasive ventilation   ICU; MODS   Alive, well
19  38        Low risk               No         ALI   Invasive ventilation   ICU; MODS   Alive, well
ALI = acute lung injury; ARF = acute renal failure; DIC = diffuse intravascular coagulopathy; CPAP = continuous postive airway pressure; MODS = multiple organ dysfunction syndrome; IUD = intra-uterine 
death; ENND = early neonatal death.




10.   Consider early use of steroids (hydrocortisone 200 mg 
daily in two divided doses) in severe H1N1 cases requiring 
intubation and ventilation.4
Prevention strategies
General and specific strategies recommended include:
1.   Distribute H1N1 information to all community health 
care centres, antenatal clinics and midwife obstetric units.5
2.   All pregnant women with flu symptoms should go to 
their community health facility and must be treated with 
oseltamivir 75 mg twice daily for 5 days. Paracetamol should 
be added for symptomatic relief. 
3.   If the patient is stable with no respiratory compromise 
she should stay at home for 7 days.
4.   If there is any change in her condition she must seek 
medical help from her health care provider.
5.   Refer women with moderate to severe respiratory 
symptoms (dyspnoea and/or a respiratory rate of >24/min) for 
evaluation to a level 2 hospital as a matter of urgency.
6.   Hospitals must have H1N1 prevention and management 
plans and inform the Department of Health, via the 
Communicable Disease Control hotline (0861-364-232), of new 
H1N1 cases and complications.
7.   Patients requiring respiratory support or with organ 
system dysfunction must be transferred to tertiary hospitals 
urgently. These patients deteriorate rapidly and are often 
difficult to transfer after intubation. In addition, the 
management of mechanical ventilation is difficult.
8.   Infection control principles should be applied rigorously:5 
•   Cohort patients.
•    The assessment area should be situated away from 
other pregnant women.
•    Admit, preferably to a medical high-care unit (HCU) or 
an ICU.
•    Pregnancy complications must be managed in an 
isolation room in the labour ward.
•    Inform and counsel all staff members regarding 
patients, precautions and occupational risk.
•   Prioritise access from rural referral hospitals.
•    Assess need for reducing ICU-dependent elective 
surgical procedures.
•   Increase ICU capacity.
9.   Neonatal aspects:
•    H1N1 does not cross the placenta and is not 
transmitted in breastmilk.
•    A stable mother with mild disease and a healthy 
baby can stay at home. Droplet and contamination 
precautions need to be adhered to, and breastfeeding 
should continue. There is no need to prescribe 
oseltamivir to a healthy neonate. Medical help must be 
sought when the neonate appears unwell.
•    Symptomatic neonates and neonates of mothers with 
severe disease must be assessed by health professionals 
trained in neonatal care. The neonatal dose for 
oseltamivir is 3 mg/kg.
In conclusion, novel influenza A (H1N1) should not be 
underestimated in pregnancy. Early oseltamivir, careful 
observation and early transfer to critical care facilities when 
indicated will decrease maternal and perinatal mortality.
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